Table 2.
Characteristics Regarding AFP Surveillance and Routine Immunizations Among Surveyed Facilities, Kenya, 2012
| Indicator | Facilities (n) | Number of Facilities Responding (N) | n/N (%) |
|---|---|---|---|
| Received quarterly supervisory visits in previous 12 mo | 18 | 41 | 44 |
| Conducted surveillance refresher trainings in last 12 mo | 19 | 41 | 41 |
| Conducted daily immunizations | 33 | 36 | 92 |
| Provided vaccine any time an eligible child presented at the facility | 28 | 33 | 85 |
| Routine immunization microplans observed | 9 | 41 | 22 |
| Routine immunization microplans reviewed on a schedule | 1 | 36 | 3 |
| Catchment area map observed | 14 | 37 | 38 |
| Conducted outreach sessions | 26 | 39 | 67 |
| Conducted all planned outreach sessions | 10 | 39 | 26 |
| Surveillance staff stated accurate AFP case definition | 33 | 41 | 80 |
| Surveillance discussed at supervisory visits | 22 | 41 | 54 |
| Registered new births | 8 | 41 | 22 |
| Tracked immunization defaulters | 16 | 41 | 39 |
| Conducted mobilization sessions for immunization | 22 | 41 | 53 |
| Inventory log was consistent with vaccine supply | 12 | 41 | 29 |
| Calculated wastage rate | 17 | 41 | 41 |
| BCG stock-outs occurred | 15 | 41 | 37 |
| Insufficient supply of syringes | 8 | 32 | 25 |
| Insufficient supply of diluent | 7 | 41 | 17 |
Total health facilities = 41.
Abbreviations: AFP, acute flaccid paralysis; BCG, bacillus Calmette-Guérin.